Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 20736371)

1.

Deficiency of splicing factor 1 suppresses the occurrence of testicular germ cell tumors.

Zhu R, Heaney J, Nadeau JH, Ali S, Matin A.

Cancer Res. 2010 Sep 15;70(18):7264-72. doi: 10.1158/0008-5472.CAN-10-0820. Epub 2010 Aug 24.

2.
3.

What leads from dead-end?

Matin A.

Cell Mol Life Sci. 2007 Jun;64(11):1317-22. Review.

4.

The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours.

Youngren KK, Coveney D, Peng X, Bhattacharya C, Schmidt LS, Nickerson ML, Lamb BT, Deng JM, Behringer RR, Capel B, Rubin EM, Nadeau JH, Matin A.

Nature. 2005 May 19;435(7040):360-4.

5.

Testicular germ cell tumor susceptibility genes from the consomic 129.MOLF-Chr19 mouse strain.

Zhu R, Ji Y, Xiao L, Matin A.

Mamm Genome. 2007 Aug;18(8):584-95. Epub 2007 Aug 2.

6.

Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing.

Shitashige M, Naishiro Y, Idogawa M, Honda K, Ono M, Hirohashi S, Yamada T.

Gastroenterology. 2007 Mar;132(3):1039-54. Epub 2007 Jan 5.

PMID:
17383426
7.
8.

Search for testicular cancer gene hits dead-end.

Matin A, Nadeau JH.

Cell Cycle. 2005 Sep;4(9):1136-8. Epub 2005 Sep 6. Review.

9.

Susceptibility to testicular germ-cell tumours in a 129.MOLF-Chr 19 chromosome substitution strain.

Matin A, Collin GB, Asada Y, Varnum D, Nadeau JH.

Nat Genet. 1999 Oct;23(2):237-40.

PMID:
10508525
10.

The role of the mouse y chromosome on susceptibility to testicular germ cell tumors.

Anderson PD, Lam MY, Poirier C, Bishop CE, Nadeau JH.

Cancer Res. 2009 Apr 15;69(8):3614-8. doi: 10.1158/0008-5472.CAN-08-4881. Epub 2009 Apr 7.

11.
12.

Vitamin D metabolism and effects on pluripotency genes and cell differentiation in testicular germ cell tumors in vitro and in vivo.

Blomberg Jensen M, Jørgensen A, Nielsen JE, Steinmeyer A, Leffers H, Juul A, Rajpert-De Meyts E.

Neoplasia. 2012 Oct;14(10):952-63.

13.

Transgenerational epigenetic effects of the Apobec1 cytidine deaminase deficiency on testicular germ cell tumor susceptibility and embryonic viability.

Nelson VR, Heaney JD, Tesar PJ, Davidson NO, Nadeau JH.

Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):E2766-73. doi: 10.1073/pnas.1207169109. Epub 2012 Aug 24.

14.

PCPH expression is an early event in the development of testicular germ cell tumors.

Regadera J, Blánquez MJ, González-Peramato P, Nistal M, Miller JC, Tirado OM, Notario V.

Int J Oncol. 2006 Mar;28(3):595-604.

PMID:
16465363
15.
16.

Interaction between DMRT1 function and genetic background modulates signaling and pluripotency to control tumor susceptibility in the fetal germ line.

Krentz AD, Murphy MW, Zhang T, Sarver AL, Jain S, Griswold MD, Bardwell VJ, Zarkower D.

Dev Biol. 2013 May 1;377(1):67-78. doi: 10.1016/j.ydbio.2013.02.014. Epub 2013 Mar 6.

17.

Chromosome X modulates incidence of testicular germ cell tumors in Ter mice.

Hammond S, Zhu R, Youngren KK, Lam J, Anderson P, Matin A.

Mamm Genome. 2007 Dec;18(12):832-8. Epub 2007 Nov 30.

18.

Testicular germ cell tumors in mice: new ways to study a genetically complex trait.

Heaney JD, Nadeau JH.

Methods Mol Biol. 2008;450:211-31. doi: 10.1007/978-1-60327-214-8_15.

PMID:
18370062
19.
20.

Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.

Mueller T, Mueller LP, Luetzkendorf J, Voigt W, Simon H, Schmoll HJ.

Tumour Biol. 2006;27(2):71-83. Epub 2006 Mar 24.

PMID:
16557044
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk